sub:assertion {
  d:DB01271 v:identifier "DB01271" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB01271" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB01271> ;
    dv:drugbank-id "DB01271" ;
    dv:x-atc <http://bio2rdf.org/atc:A16AB09> ;
    dv:x-cas <http://bio2rdf.org/cas:50936-59-9> ;
    dv:x-ndc <http://bio2rdf.org/ndc:54092-700-01> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA164749134> ;
    dv:x-wikipedia <http://bio2rdf.org/wikipedia:Idursulfase> ;
    dct:description "Idursulfase is a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal iduronate sulfate residues from the glycosaminoglycans dermatan sulfate and heparan sulfate in the lysosomes of various cell types. Idursulfase is a 525-amino acid glycoprotein with a molecular weight of approximately 76 kilodaltons. The enzyme contains eight asparagine-linked glycosylation sites occupied by complex oligosaccharide structures. The enzyme activity of idursulfase is dependent on the post-translational modification of a specific cysteine to formylglycine."@en ;
    dct:identifier "drugbank:DB01271" ;
    dct:title "Idursulfase"@en ;
    a dv:Drug ;
    rdfs:label "Idursulfase [drugbank:DB01271]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB01271> , <http://www.drugs.com/cdi/idursulfase.html> .
}